VIR Q4 2019 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$980,000+16233.3% YoY

Gross Profit

-$53M-5384.7% margin

Operating Income

-$64M-6506.0% margin

Net Income

-$64M-6507.2% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

+313.5%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$512M

Total Liabilities

$88M

Stockholders' Equity

$424M

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$980,000	$6,000	+16233.3%
Gross Profit	-$53M	-$24M	-121.6%
Operating Income	-$64M	-$27M	-137.9%
Net Income	-$64M	-$26M	-141.6%

Revenue Segments

Grant

$609,000100%